Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
The Associated Press - Friday, October 4, 1996
The ruling allows sales across the 15-nation EU of the two drugs -- Crixivan, made by Merck & Co. of the United States, and Invirase, produced by Swiss pharmaceutical company Roche Holding Ltd.
"These medicines offer new chances against AIDS," said EU spokesman Jochen Kubosch.
Crixivan and Invirase belong to a new class of AIDS drugs called protease inhibitors that target the protease enzyme needed in the reproduction of HIV, the virus causing AIDS. By hindering the virus' reproduction, the drugs can sharply reduce the amount of virus circulating in the blood.
Both drugs have already been approved for sale in the United States by the U.S. Food and Drug Administration.
961004
AP961003
Copyright © 1996 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .